Finanziari

  • Market Capitalization 20.68 M
  • Employee 70
  • Founded 2005
  • CEO N/A
  • Website www.igcinc.us
  • Headquarter Maryland, United States
  • FIGI BBG000NSSLY8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.17
Rapporto prezzo/fatturato
17.16

Ticker correlati

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4397
ATOS
Atossa Therapeutics, Inc. - Common Stock
2.23 USD-5.91%-17.10%+12.06%+156.32%22.25 M USD
4406
BYSI
BeyondSpring, Inc. - Ordinary Shares
0.52 USD0.00%+13.04%-25.71%-71.43%21.38 M USD
4435
KPTI
Karyopharm Therapeutics Inc. - Common Stock
0.87 USD+4.82%+70.59%-30.95%-90.98%19.73 M USD
4437
MCRB
Seres Therapeutics, Inc. - Common Stock
1.96 USD+9.50%-6.67%-43.52%-76.18%19.48 M USD

Notizie